Wilson Sonsini Goodrich & Rosati’s 2019 Mid-Year Technology and Life Sciences IPO Report presents analysis related to the pricing of 49 initial public offerings completed by U.S.-based technology and life sciences issuers between January 1 and June 30, 2019. The report includes IPO filing, pricing, and value statistics for both sectors; governance and board of director details; ownership and structure factors; defensive measure data; and other matters. WSGR’s report shows that, at the mid-point of 2019, IPO totals were similar to those at the mid-point of 2018, despite the U.S. government shutdown that substantially slowed IPOs in early 2019. IPO totals during the second quarters of both 2018 and 2019 were significantly higher than the first quarter totals for each year.
Please see full publication below for more information.